Urologic Oncology: Seminars and Original Investigations
Volume 28, Issue 4 , Pages 360-367 , July 2010

Altered antioxidant status and lipid peroxidation in Indian patients with urothelial bladder carcinoma

  • Nitika Badjatia, M.Sc.

      Affiliations

    • Department of Biochemistry, All India Institute of Medical Sciences, New Delhi, India
    • ,
  • Abhigyan Satyam, M.Sc.

      Affiliations

    • Department of Biochemistry, All India Institute of Medical Sciences, New Delhi, India
    • ,
  • Prabhjot Singh, M.S.

      Affiliations

    • Department of Urology, All India Institute of Medical Sciences, New Delhi, India
    • ,
  • Amlesh Seth, M.Ch.

      Affiliations

    • Department of Urology, All India Institute of Medical Sciences, New Delhi, India
    • ,
  • Alpana Sharma, Ph.D.

      Affiliations

    • Department of Biochemistry, All India Institute of Medical Sciences, New Delhi, India
    • Corresponding Author InformationCorresponding author. Tel.: +0091-9899061974; fax: +0091-11-26588641

Received 3 October 2008 ,Revised 1 December 2008 ,Accepted 2 December 2008.

References 

  1. Macvicar AD. Bladder cancer staging. BJU Int. 2000;86(Suppl. 1):111–122
  2. Metts MC, Metts JC, Milito SJ, et al. Bladder Cancer: A review of diagnosis and management. J Natl Med Assoc. 2000;92:285–294
  3. Lamm DL, Griffith JG. Intravesical therapy; does it affect the natural history of bladder cancer?. Sem Urol. 1992;10:39–44
  4. Hukaas S, Daehlin L, Maartman-Moe H, et al. The long term outcome in patients with superficial urothelial carcinoma of the bladder: A single-institutional experience. BJU Int. 1999;83:957–963
  5. Mohandas J, Marshall JJ, Duggin GG, et al. Low activities of glutathione-related enzymes as factors in the genesis of urinary bladder cancer. Cancer Res. 1984;44:5086–5091
  6. Helzlsouer KJ, Comstock GW, Morris JS. Selenium, lycopene, α-tocopherol, β-carotene, retinol, and subsequent bladder cancer. Cancer Res. 1989;49:6144–6148
  7. Yalcin O, Karatas F, Erulas FA, et al. The levels of glutathione peroxidase, vitamins A, E, C, and lipid peroxidation in patients with urothelial carcinoma of the bladder. BJU Int. 2004;93:863–866
  8. Arikan S, Akcay T, Konukoglu D, et al. The relationship between antioxidant enzymes and bladder cancer. Neoplasma. 2005;52:314–317
  9. Marnett LJ. Oxyradicals and DNA damage. Carcinogenesis. 2000;21:361–370
  10. Valko M, Izakovic M, Mazur M, et al. Role of oxygen radicals in DNA damage and cancer incidence. Mol Cell Biochem. 2004;266:37–56
  11. Das U. A radical approach to cancer. Med Sci Monit. 2002;8:79–92
  12. Kong Q, Beel JA, Lillehei KO. A threshold concept for cancer therapy. Med Hypotheses. 2000;55:29–35
  13. Brown NS, Bicknell R. Hypoxia and oxidative stress in breast cancer: Oxidative stress, its effects on the growth, metastatic potential, and response to therapy of breast cancer. Breast Cancer Res. 2001;3:323–327
  14. Kumar B, Koul S, Khandrika L, et al. Oxidative stress is inherent in prostate cancer cells and is required for aggressive phenotype. Cancer Res. 2008;68:1777–1785
  15. Toyokuni S, Okamoto K, Yodoi J, et al. Persistent oxidative stress in cancer. FEBS Lett. 1995;358:1–3
  16. Ushio-Fukai M, Nakamura Y. Reactive oxygen species and angiogenesis: NADPH oxidase as target for cancer therapy. Cancer Lett. 2008;266:37–52
  17. Nishikawa M. Reactive oxygen species in tumor metastasis. Cancer Lett. 2008;266:53–59
  18. Niedernhofer LJ, Daniels JS, Rouzer CA, et al. Malondialdehyde, a product of lipid peroxidation, is mutagenic in human cells. J Biol Chem. 2003;278:31426–31433
  19. Goodyear-Bruch C, Pierce JD. Oxidative stress in critically ill patients. Am J Crit Care. 2002;11:543–551
  20. Mates JM, Perez-Gomez C, de Castro IN. Antioxidant enzymes and human diseases. Clin Biochem. 1999;32:595–603
  21. Halliwell B, Gutteridge JMC. Free radicals in biology and medicine. Oxford: Clarendon Press; 1985;
  22. Inal ME, Kanbak G, Sunal E. Antioxidant enzyme activities and malondialdehyde levels related to aging. Clin Chim Acta. 2001;305:75–80
  23. Halliwell B. Free radical antioxidants in human diseases; curiosity, cause or consequence. Lancet. 1994;344:72–74
  24. Kolonel LN, Hins MW, Nomura AM, et al. Relationship of dietary vitamin A and ascorbic acid intake to the risk of cancers of the lung, bladder, and prostate in Hawaii. Nat Cancer Inst Monogr. 1985;69:137–142
  25. Kamat AM, Lamm DL. Chemoprevention of bladder cancer. Urol Clin North Am. 2002;29:157–168
  26. McCormick DB, Green HL. Vitamins. In:  Carl A,  Burtis CA,  Edward R, et al. editor. Tietz Textbook of Clinical Chemistry. New Delhi: W. B. Saunders; 1999;p. 1024–1025
  27. Paglia DE, Valentine WN. Studies on the quantitative and qualitative characterization of erythrocyte glutathione peroxidase. J Lab Clin Med. 1967;70:158–169
  28. Yoshioka T, Kawada K, Shimada T, et al. Lipid peroxidation in maternal and cord blood and protective mechanisms against activated oxygen toxicity in the blood. Am J Obster Gynecol. 1979;135:372–376
  29. Koracevic D, Koracevic G, Djordjevic V, et al. Method for the measurement of antioxidant activity in human fluids. J Clin Pathol. 2001;54:356–361
  30. Valko M, Rhodes CJ, Moncol J, et al. Free radicals, metals, and antioxidants in oxidative stress-induced cancer. Chem Biol Interact. 2006;160:1–40
  31. Aymelek G, Erten D, Aslan S, et al. Lipid peroxidation and antioxidant status in blood and tissue of malignant breast tumor and benign breast disease. Cell Biol Int. 2006;30:376–380
  32. Beevi SS, Rasheed MH, Geetha A. Evidence of oxidative and nitrosative stress in patients with cervical squamous cell carcinoma. Clin Chim Acta. 2007;375:119–132
  33. Sharma A, Rajjapa M, Saxena A, et al. Antioxidant status in advanced cervical cancer patients undergoing neoadjuvant chemoradiation. Br J Biomed Sci. 2007;64:23–27
  34. Zaidi SM, Al-Qirim TM, Banu N. Effects of antioxidant vitamins on glutathione depletion and lipid peroxidation induced by restraint stress in the rat liver. Drugs R D. 2005;6:157–165
  35. Jacob RA, Burn BJ. Oxidative damage and defense. Am J Clin Nutr. 1996;63:985S–990S
  36. Knekt P, Aromaa A, Maatela J. Vitamin E and cancer prevention. Am J Clin Nutr. 1991;53:283S–286S
  37. Kudo K, Suwa J. Inhibitory effect of vitamin E on rats with bladder tumors induced by N-butyl-N-(4-hydroxybutyl) nitrosamine. Hinyokika Kiyo. 1992;38:399–404
  38. Oberley LW, Bueftner GR. Role of superoxide dismutase in cancer: A review. Cancer Res. 1979;39:1141–1149
  39. Kaczmarek P, Buczyński A, Niemirowicz J, et al. Lipids peroxidation in platelets in patients with bladder cancer treated with Mycobacterium suspension. Pol Merkur Lekarski. 2001;11:484–486
  40. Savic-Radojevic A, Mimic-Oka J, Pljesa-Ercegovac M, et al. Glutathione S-transferase-P1 expression correlates with increased antioxidant capacity in urothelial carcinoma of the urinary bladder. Eur Urol. 2007;52:470–477
  41. Ozmen H, Erulas FA, Karatas F, et al. Comparison of the concentration of trace metals (Ni, Zn, Co, Cu, and Se), Fe, vitamins A, C, and E, and lipid peroxidation in patients with prostate cancer. Clin Chem Lab Med. 2006;44:175–179
  42. Tas F, Hansel H, Belce A, et al. Oxidative stress in breast cancer. Med Oncol. 2005;22:11–15
  43. Gönenç Y, Özkan M, Torun BçS. Plasma malondialdehyde (MDA) levels in breast and lung cancer patients. J Clin Pharm Ther. 2001;26:141–144
  44. Esme H, Cemek M, Sezer M, et al. High levels of oxidative stress in patients with advanced lung cancer. Respirology. 2008;13:112–116
  45. Pigeolet E, Corbisier P, Houbion A, et al. J. Glutathione peroxidase, superoxide dismutase, and catalase inactivation by peroxide and oxygen derived free radical. Mech Aging Dev. 1990;51:283–297
  46. Blum J, Fridovich I. Inactivation of glutathione peroxidase by superoxide radical. Arch Biochem Biophys. 1985;240:500–508
  47. Baker AM, Oberley LW, Cohen MB. Expression of antioxidant enzymes in human prostatic adenocarcinoma. Prostate. 1997;32:229–233
  48. Aydin A, Arsova-Sarafinovska Z, Sayal A, et al. Oxidative stress and antioxidant status in non-metastatic prostate cancer and benign prostatic hyperplasia. Clin Biochem. 2006;36:176–179
  49. Borek C. Dietary antioxidants and human cancer. Integr Cancer Ther. 2004;3:333–341
  50. Halliwell B. Effect of diet on cancer development: Is oxidative DNA damage a biomarker. Free Radic Biol Med. 2002;15:968–974
  51. Marikovsky M, Nevo N, Vadai E, et al. Cu/Zn superoxide dismutase plays a role in angiogenesis. Int J Cancer. 2002;97:34–41
  52. Clerkin JS, Naughton R, Quiney C, et al. Mechanisms of ROS modulated cell survival during carcinogenesis. Cancer Letts. 2008;266:30–36

☆ This work was financially supported by Indian Council of Medical Research, New Delhi, India.

PII: S1078-1439(08)00353-0

doi: 10.1016/j.urolonc.2008.12.010

Urologic Oncology: Seminars and Original Investigations
Volume 28, Issue 4 , Pages 360-367 , July 2010

Article Tools

* Image Usage & Resolution